How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Monitoring & Cardiac Monitoring Devices Market
- By Product Type: Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Electrocardiogram (ECG) Monitors, Holter Monitors, Cardiac Event Monitors
- By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Laboratories, Ambulatory Surgical Centers
- By Technology: Continuous Glucose Monitoring (CGM) Systems, Non-invasive Blood Pressure Monitors, Wearable Cardiac Monitors, Implantable Cardiac Monitors, Portable ECG Devices
- By Application: Diabetes Management, Hypertension Monitoring, Cardiac Arrhythmia Detection, Postoperative Cardiac Care, Sleep Apnea Monitoring
- By Connectivity Type: Bluetooth-enabled Devices, Wi-Fi Enabled Devices, USB-connected Devices, Standalone Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Blood Glucose Monitors leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.185 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.193 →
Full report · locked preview
Everything inside the Blood Monitoring & Cardiac Monitoring Devices Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 6
End User 5
Technology 5
Application 5
Connectivity Type 4
Companies profiled
Abbott Laboratories
Medtronic plc
Siemens Healthineers
GE Healthcare
Philips Healthcare
Fresenius Medical Care
Becton Dickinson and Company (BD)
Roche Diagnostics
Nipro Corporation
Edwards Lifesciences
Terumo Corporation
Masimo Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fresenius Medical Care
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Becton Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Roche Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Edwards Lifesciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Terumo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Masimo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Dexcom Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioTelemetry Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Natus Medical Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$6,860M by 2033 · 5.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Blood Glucose Monitors36.8
- Blood Pressure Monitors12.2
- Pulse Oximeters11.4
- Electrocardiogram (ECG) Monitors9.5
- Holter Monitors15.9
- Cardiac Event Monitors14.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,458M → $2,439M · 6.6%
Europe$1,016M → $1,639M · 6.2%
Asia Pacific$927.7M → $1,575M · 6.8%
Latin America$574.3M → $936.4M · 6.3%
Middle East and Africa$441.7M → $638.8M · 4.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.622026
5.622027
5.632028
5.652029
5.662030
5.672031
5.682032
5.692033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories13.5
- Medtronic plc23.9
- Siemens Healthineers7.0
- GE Healthcare11.4
- Philips Healthcare9.2
- Fresenius Medical Care7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type14.1%
End User15.4%
Technology22.7%
Application24.0%
Connectivity Type23.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.7
- Europe22.7
- Asia Pacific21.8
- Latin America13.0
- Middle East and Africa8.8
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 75 | 88 | 91 | 93 | 93 | 78 | 86 |
| Medtronic plc | 82 | 80 | 83 | 84 | 83 | 83 | 83 |
| Siemens Healthineers | 80 | 83 | 70 | 70 | 72 | 72 | 75 |
| GE Healthcare | 61 | 66 | 74 | 68 | 59 | 58 | 64 |
| Philips Healthcare | 58 | 54 | 75 | 65 | 58 | 71 | 64 |
| Fresenius Medical Care | 59 | 51 | 48 | 48 | 53 | 66 | 54 |
| Becton Dickinson and Company (BD) | 56 | 50 | 59 | 61 | 61 | 42 | 55 |
| Roche Diagnostics | 56 | 56 | 40 | 40 | 47 | 45 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Medtronic plc | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Siemens Healthineers | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| GE Healthcare | ◐ | − | ◐ | − | ◐ | ◐ |
| Philips Healthcare | − | − | ◐ | ◐ | − | ◐ |
| Fresenius Medical Care | ◐ | − | − | ◐ | − | ◐ |
| Becton Dickinson and Company (BD) | − | − | ◐ | ◐ | ◐ | − |
| Roche Diagnostics | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Abbott Laboratories86
2Medtronic plc83
3Siemens Healthineers75
4GE Healthcare64
5Philips Healthcare64
6Becton Dickinson and Company (BD)55
7Fresenius Medical Care54
8Roche Diagnostics47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Abbott LaboratoriesMedtronic plc
Challenger1
Strong scale, closing on the leaders.
Siemens Healthineers
Contender2
Focused players with pockets of strength.
GE HealthcarePhilips Healthcare
Niche3
Specialists in a single segment or region.
Fresenius Medical CareBecton Dickinson and Company (BD)Roche Diagnostics
Go-to-market strategy
Land Product Type in North America, then scale across Blood Monitoring & Cardiac Monitoring Devices Market — a $144M beachhead inside a $2.29B market.
Beachhead (SOM)$144Mobtainable near-term
Serviceable (SAM)$891Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Blood Glucose Monitors
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Blood Pressure Monitors
Strong fit — clear ROI and a fast path to value.
End user64 fit
Pulse Oximeters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Monitoring & Cardiac Monitoring Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified20%
Evaluation15%
Closed-won7%
$9.4KCAC
$48KLTV
5.1:1LTV : CAC
< 4 moCAC payback
Investment thesis
Blood Monitoring & Cardiac Monitoring Devices Market is a durable-growth opportunity — $4.69B by 2033, compounding at 6.9%.
TAM · 2025$2.75Btoday
TAM · 2033$4.69Bforecast
CAGR6.9%2027–2033
Cumulative$32.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.69BTotal addressable market
SAM$1.94BServiceable available market
SOM$423MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.69BLarge & growingTAM by 2033 at 6.9% CAGR
$1.94BServiceable nowreachable with today’s model
$423MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.66BBear4.5% CAGR
$4.69BBase6.9% CAGR
$6.01BBull9.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Monitoring & Cardiac Monitoring Devices Market — a $7.24B market by 2033. Plan: grow share from 11.8% to 18.5%.
Market size · 2033$7.24Btotal addressable
Market CAGR8.3%2027–2033
Target share18.5%from 11.8% today
Revenue ambition$1.34Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.8% | 18.5% | On track |
| Revenue | $871M | $1.34B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.5% | 44.8% | At risk |
| Customer retention | 88.6% | 96.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $149M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Sales deck · value proposition
Win the Blood Monitoring & Cardiac Monitoring Devices Market conversation — a $6.71B market you can size, segment and defend in minutes.
Market size · 2033$6.71Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers980+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 4 mopayback period
$42K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Abbott LaboratoriesMedtronic plcSiemens HealthineersGE HealthcarePhilips HealthcareFresenius Medical CareBecton Dickinson and Company (BD)Roche Diagnostics+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Monitoring & Cardiac Monitoring Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Monitoring & Cardiac Monitoring Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Monitoring Device Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportBlood Orange Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportBlood Oxygen Measurement Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBlood Plasma Fibrinogen Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBlood Plasma Freezer Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBlood Platelet Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBlood Pressure Kiosk Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBlood Pressure Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBlood Pressure Monitor Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportBlood Pressure Monitoring Sensors Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportBlood Pressure Sensor Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBlood Pressure Transducer Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.